2025 offering

Neuro Spectrum Insights IPO

Neuro Spectrum Insights develops software to support autism diagnosis through MRI image analysis.

  • NSIH
  • NYSE American
  • United States
  • Healthcare
Filed 20 Jun 2025

Offering in progress. A listing date has not been announced, and proposed terms may change.

Last verified 15 Oct 2026
Indicative valuation
$60.4M to $75.4MBasic equity value after the offering
Price range
$4.00 to $5.00Per share · USD
Offering size
$15M to $18.8MBase offering, before overallotment

Its first product, GyriCalc, is proprietary and patented software. It automates the measurement and analysis of MRI images to identify early structural markers of neurodevelopmental differences and assist in autism diagnosis.

Company country
United States

Offering details

USD · Base offering, before overallotment

Exchange
NYSE American
Ticker
NSIH
Shares offered
3,750,000
Shares after offering
15,087,815